J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
HealthVerity recently introduced HealthVerity Notes, our newest product designed to unlock the...
AI-driven mortality models are supposed to provide accurate, data-backed insights into patient...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
GLP-1 Trends: Ozempic and Semaglutide drive a 587% spike in prescriptions Prescriptions for GLP-1...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Why data provenance matters for regulatory submissions and clinical trials Regulators increasingly...
This is part three of a three-part series on the essential qualities of claims data for life...
This is part two of a three-part series (read part 1, part 3) on the essential qualities of claims...
This is part one of a three-part series (read part 2, part 3) on the essential qualities of claims...
AI is playing a growing role in real-world evidence, but not all AI serves the same purpose. Two terms often used interchangeably, Generative AI and Agentic AI, describe very different capabilities and the distinction matters in real-world evidence (...